CD28 and neoplasm: Additionally, the nanobody-based BCMA CAR-NK exhibited remarkable specific killing ability in vitro, BCMA-CD28-IL15 CAR-NK especially inhibited the growth of tumor cells and prolonged survival of MM mouse model [222].